Extending limits of resection for metastatic colorectal cancer: Risk benefit ratio

Anthony D. Yang, Antoine Brouquet, Jean Nicolas Vauthey

Research output: Contribution to journalArticle

17 Scopus citations

Abstract

Improvements in treatment strategies and a better knowledge of tumor biology have contributed to an increase in the number of patients with colorectal liver metastases (CLM) who are candidate for surgery. These progresses are on going and the introduction of effective systemic therapy agents contributes further to the increase in the resectability of patients with advanced CLM. © 2010 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)996-1001
Number of pages6
JournalJournal of Surgical Oncology
Volume102
Issue number8
DOIs
StatePublished - Dec 15 2010
Externally publishedYes

Keywords

  • chemotherapy
  • colorectal cancer
  • liver metastases
  • resectability

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Extending limits of resection for metastatic colorectal cancer: Risk benefit ratio'. Together they form a unique fingerprint.

Cite this